Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I wrote to Cam and here is what his people answered me back. I asked some questions and got some answers. Nust say they are experts at answering. To me a bit unsettling but better something than nothing. See what you guys make out of it.
I work with Cam in the investor relations department. I’ve taken a look at your questions and broken them down to try to answer them best.
When do you propose that ACB is gonna engage in a buyback program.
At this time, Aurora has not initiated a share buy back program nor has it announced any planned to do so. At this juncture in our growth, we feel it appropriate to invest our capital into continuing to grow our business. That said, in the future as the company becomes cash flow positive, that is an option it may consider pursuing.
Are you having a hard time with the banks? If so, Why?
Aurora has not announced any issues with “the banks”. In fact, we recently closed the largest debt financing in the cannabis industry with BMO.
The stock market goes up dramatically and ACB goes up pennies. Whats up with that?
Without quantifying the specific period you’re looking at, this is a difficult question to answer. Without being overly general in my response, the broader cannabis industry has experienced a prolonged period of volatile valuations over the past 18 months. During this time, we’ve seen extreme periods of upward and downward pressure on share prices. Aurora, like other LP’s, is not immune to these broader market cycles like what has occurred following implementation of bill C-45 in Canada, where the entire industry experienced and abrupt decline in share prices.
Wheres all the big announcements that will make this stock take off?
Aurora continues to provide the market with regular updates on its activities when possible. Our practice remains to only announce details once potential transactions are finalized.
You seem to be dodging the outstanding shares questions everytime you're asked about it.
What specifically is the question you’re asking here? Aurora has issued shares in order to acquire strategic assets which have allowed us to significantly ramp our scale and production capacity. Happy to discuss this further with you once you clarify the ask here.
All the other cannibus stocks soared when they hit the American markets ours did a tank. What's up with that?
As noted above, following implementation of the bill C-45 in Canada, the broader industry experienced a significant market downturn. Our US listing unfortunately happened to coincide with that event.
Rumors here about insiders selling off , how true is that? If so why?
Can you provide more information with respect to the rumours you’re hearing about insider selling?
Should you have any other questions or wish to discuss this further, please feel free to reach out. I’m happy to assist.
Robert Kelly Director, Investor Relations
This is good news out today .I know the Poland thing is not new but read on.Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB) recently announced that Polish Ministry of Health granted the Company approval for its first shipment of medical cannabis to Poland. In the coming days, Aurora Deutschland GmbH will ship the products to a pain treatment center and a hospital in Warsaw. This is an important milestone for medical patients in Poland, as it is believed to be the first time a non-government run business has been granted approval to supply medical cannabis products in the country. Under Polish legislation, physicians can prescribe medical cannabis products to patients who can then access it through registered pharmacies. In specific instances, products will be covered under statutory health insurance, thus establishing a new and significant medical market for Aurora. "Becoming the first company to supply cannabis to Poland is validation of Aurora's ability to do business in international markets with high barriers to entry," said Neil Belot, Chief Global Business Development Officer. "This is an important milestone for patient access in Poland, which will provide options for people seeking alternative medications to help manage symptoms of a wide range of medical conditions. Aurora continues to grow its international footprint, which now spans 19 countries on five continents, and puts us in an enviable position to capitalize on our early mover advantage."
OK OK!
Sorry humanchessmachine did'nt mean to ruffle your feathers. Was just stating the facts. Next time will wait for you to pump and dump. So So Sorry.
At the moment, Aurora Cannabis has annual revenues of CAD$55.2 million, an operating loss of CAD$95.8 million, cash and marketable securities of CAD$149.4 million, CAD$9.2 million in long-term debt, and CAD$191.5 million in unsecured convertible notes with a 5% interest rate and a conversion price of CAD$13.05.
It also has a CAD$150 million term loan that it got through the Bank of Montreal (NYSE:BMO) in August after the close of its fourth quarter, along with a CAD$50 million credit facility that can be upped to CAD$250 million if it meets certain conditions.
Factor that all in and Aurora currently has net debt of CAD$51 million. That’s likely to increase as it takes on more debt to finance its operations around the world, as are its operating losses.
PS I have spent the last hour researching if Insiders have sold shares of Aurora lately. I could not come up with one single person that sold so I dont know who put that out there but I respectfully think they might have been ill informed.Just ask your broker people they will be more than happy to tell you.Chill!
no its the street.
RECOMMENDATION
We rate AURORA CANNABIS INC (ACB) a HOLD. The primary factors that have impacted our rating are mixed
- some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either
a positive or negative performance for this stock relative to most other stocks. The company's strengths can
be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable
debt levels by most measures and solid stock price performance. However, as a counter to these strengths,
we find that we feel that the company's cash flow from its operations has been weak overall.
HIGHLIGHTS
ACB's very impressive revenue growth greatly exceeded the industry average of 4.7%. Since the same
quarter one year prior, revenues leaped by 222.6%. Growth in the company's revenue appears to have helped
boost the earnings per share.
ACB's debt-to-equity ratio is very low at 0.13 and is currently below that of the industry average, implying that
there has been very successful management of debt levels. To add to this, ACB has a quick ratio of 2.19,
which demonstrates the ability of the company to cover short-term liquidity needs.
The company's current return on equity greatly increased when compared to its ROE from the same quarter
one year prior. This is a signal of significant strength within the corporation. Compared to other companies in
the Pharmaceuticals industry and the overall market on the basis of return on equity, AURORA CANNABIS
INC underperformed against that of the industry average and is significantly less than that of the S&P 500.
Net operating cash flow has significantly decreased to -$45.12 million or 1062.88% when compared to the
same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much
lower.
PS insiders cannot dump their shares at their whim! The are laws rules and guidelines to follow before they can do that. I think if Im not mistaken they have to announce it 3 months prior to selling precisly for that reason.So that debunks the theory of they knew what was going on so the hurried up and dumped. Hey its the stock marker were talking about.
Reverrand you have a point , however if that were the case Aurora would have jumped at any money making partnership to avoid that. I do think that institutions are on sidelines waiting to get more bang for their buck. Having said that the whole market is down wickedly, Almost every sector other than retail is in the red today. So ofcourse its gonna drag us down.Im getting ready to buy a lot more at a lower price. No company would spend as much money as Aurora did and plan on losing that would be ludicrous.. When it starts going up its gonna soar.
Banks are cautious about lending monies especially because of the vagueness of the US laws. However they are coming around slowly. Hope the beat expectations in November. Unbelievable market so high and Aroura going in Red territory.We need a big announcement to anchor this stock on NYSE or else it will be delisted if it continues to drop. I think it will make a remarkable turnaround. They are running out of mj all over the place and ACB has plenty of it and the best. So we'll see.
STOCK-AT-A-GLANCE
Below is a summary of the major fundamental and technical factors we consider when determining our
overall recommendation of ACB shares. It is provided in order to give you a deeper understanding of our
rating methodology as well as to paint a more complete picture of a stock's strengths and weaknesses. It is
important to note, however, that these factors only tell part of the story. To gain an even more comprehensive
understanding of our stance on the stock, these factors must be assessed in combination with the stock’s
valuation. Please refer to our Valuation section on page 5 for further information.
FACTOR SCORE
Growth 2.0 out of 5 stars
Measures the growth of both the company's income statement and
cash flow. On this factor, ACB has a growth score better than 30% of
the stocks we rate.
weak strong
Total Return 5.0 out of 5 stars
Measures the historical price movement of the stock. The stock
performance of this company has beaten 90% of the companies we
cover.
weak strong
Efficiency 2.0 out of 5 stars
Measures the strength and historic growth of a company's return on
invested capital. The company has generated more income per dollar of
capital than 30% of the companies we review.
weak strong
Price volatility 2.0 out of 5 stars
Measures the volatility of the company's stock price historically. The
stock is less volatile than 30% of the stocks we monitor.
weak strong
Solvency 4.5 out of 5 stars
Measures the solvency of the company based on several ratios. The
company is more solvent than 80% of the companies we analyze.
weak strong
Income 0.5 out of 5 stars
Measures dividend yield and payouts to shareholders. This company
pays no dividends.
weak strong
THESTREET RATINGS RESEARCH METHODOLOGY
TheStreet Ratings' stock model projects a stock's total return potential
Here’s a look at the total short interest in the top five most heavily-shorted stocks Dusaniwsky mentioned, according to S3’s latest data:
Canopy Growth: $677 million in short interest for U.S.-listed ticker, $280 million in short interest for Canadian ticker, $181.2 million in total October profits for short sellers.
Aurora Cannabis Inc (NYSE: ACB) $458 million in short interest for U.S.-listed ticker, $197 million in short interest for Canadian ticker, $128.9 million in total October profits for short sellers.
GW Pharma: $315 million in short interest, $68.3 million in October profits for short sellers.
Tilray: $306 million in short interest, $42.4 million in October profits for short sellers.
Cronos Group Inc (NASDAQ: CRON): $236 million in short interest for U.S.-listed ticker, $37 million in short interest for Canadian ticker, $70.8 million in October profits for short sellers.
In all, S3 estimates there's roughly $2.86 billion in short interest in the cannabis sector and a total of $585.7 million in profits on those shorts this month alone.
Aggressive Shorting
Dusainiwsky said short sellers seem more than willing to pay the high borrow fees for many of these stocks, which average 15.4 percent for the sector.
Another way of appreciating just how aggressive the short sellers have been in cannabis tickers is to use short percent of float:
New Age Beverages Corp (NASDAQ: NBEV): Short percent of float of 42 percent with 0.3 days to cover.
Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE): Short percent of float of 22 percent with 7.6 days to cover.
India Globalization Capital, Inc. (NYSE: IGC): Short percent of float of 18.5 percent with 0.1 days to cover.
Cronos: Short percent of float of 17 percent with 2.4 days to cover.
Canopy Growth: Short percent of float of 9 percent with 1.7 days to cover.
Bottom Not Yet In?
Market enthusiasm for the booming cannabis industry has triggered a major run in cannabis stocks in 2018, but short sellers are looking at the valuations of many of these stocks and profiting as they crash back to reality. If the latest numbers are any indication, short sellers seem to be convinced the bottom is not yet in in the marijuana space.
Related Links:
Cannot believe the Nyse over 400 pts up and Nasdaq over 200 pts up and Aurora a laggard. Even with daily news coming out Poland permit, uplisting, all that Urugway balogny,thru the roof earnings, buying everything in sight that has to do with pharma and MJ, expanding all over Europe even being told that their valuation is not as bad as once thought because of the profits of all the other companies its partnered with. Well I think its the dilution way too many outstanding shares. Credible Analysts don,t like this, It,s time to plan a buyback program. It,s also time to partner with a company that will invest 5 to 6 billion in Aurora like they did with Canopy. I mean really this is a strong company but the cash flow isnt there for buying up everything. Its spreading itself thin. On the other hand it needs these anchors. I just dont know what the answer is,but its unacceptable that the stock drops on a day like this, it should have been back to 10.Just thinking out loud.
You know if the market was up Aurora would have sailed. What a horrible day to uplist I wish the timing was better. We waited so long to go from 7 to 10 and all wiped out in a couple of hours on the biggest newsday of Aurora. Well now Aurora CEO's had better come out with some good contract deals to swing this stock up.And why are insiders selling? Are any insiders buying at all.If not why? After all they have more monies than most of us.If they believe in their company then put your money where your mouth is.NOW! Terry booth better start a buyback program.QUICK!
Reverand right as usual,
just bought few more shares before close and tomorrow's uplist. good luck all.
“At some point we anticipate the U.S. will change its regulation and make cannabis federally legal, and when that happens, we want to have an insurmountable lead already established.” That's what Cam B said in an interview with Yahoo finance. Just 37 mins ago. Sounds good to me. Stock already creeping back up before close. So Chill people!!!!!
This is intersting. check it out. Its all good.https://www.fool.com/investing/2018/10/22/4-things-aurora-cannabis-did-right-before-its-nyse.aspx
I'm thinking this is all a ploy so that when it gets listed tomorrow it will take off and be a good suprise for everyone. Also the nyse down almost 200 points not helping.Hoping the ceo's come up with some good news with new contracts and Dow goes up tomorrow significantly and catapaults Aurora along with it.It needs a catalyst along with that uplisting.
Aurora should start creeping up slowly on Monday. By Monday at close it should be quite a bit higher. Tuesday Morning it will shoot up significantly then shorters will start their game but by close the mutual funds will have taken control and stock will spike well and shorters will need a hanky. If any good news comes then, or on Wednesday, like drink co, or pharma co, or Warren Buffet looking into it for pepsi, or whatever, well, then its a new game. Skys the limit. So here we go. Good luck all.
In the last 5 days the entirStock Moves
Here are some of the top marijuana stocks (market cap above $100 million) in U.S. exchanges and how the performed over the last five trading days:
• 22nd Century Group Inc (NYSE: XXII): up 3 percent
• Aphria Inc (OTC: APHQF): down 4.5 percent
• Aurora Cannabis Inc (OTC: ACBFF): down 6 percent
• CannTrust Holdings Inc (OTC: CNTTF): down 12.6 percent
• Canopy Growth Corp (NYSE: CGC): down 6 percent
• Cronos Group Inc. (NASDAQ: CRON): down 2 percent
• Green Organic Dutchman Holdings Ltd (OTC: TGODF): down 16.5 percent
• Green Thumb Industries Inc (OTC: GTBIF): up 2.8 percent
• GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH): down 0.4 percent
• iAnthus Capital Holdings Inc (OTC: ITHUF): up 7.3 percent
• Medical Marijuana Inc (OTC: MJNA): down 5 percent
• MedMen Enterprises Inc. (OTC: MMNFF): up 5.9 percent
• Scotts Miracle-Gro Co (NYSE: SMG): down 0.6 percent
• THC Biomed Intl Ltd (OTC: THCBF): down 8.5 percent
• Tilray Inc (NASDAQ: TLRY): down 1.9 percente MJ sector was down,but why is the question,
Reverand should have been higher today. something daunting. Reverand thanks for being real. You always make a lot of sense. Always look forward to your posts.Analysts are saying valuation not bad. we'll see Tuesday.
Aurora should have moved up yesterday and today significantly.The fact that it didnt and even though it means nothing, the after close drop is quiet unsettling to me.We kinda have one more chane and that is the listing.Hopefully it will be on an upswing day. Relying on large institutional buying and drink deals and oils and big pharma etc. Hopefully the price will not be factored in and it will swing quite higher. Valuation seems good thanks to other companies Aurora had invested in which pushed it's financial higher. What's Cam Baetly up to these days?
e: IIROC Trading Halt - ACB
10:00 am ET October 16, 2018 (Dow Jones) Print
IIROC Trading Halt - ACB
Canada NewsWire
TORONTO, Oct. 16, 2018
TORONTO, Oct. 16, 2018 /CNW/ - The following issues have been halted by IIROC:
Company: Aurora Cannabis Inc.
TSX Symbol: ACB
Reason: Single Stock Circuit Breaker
Halt Time (ET): 9:52:30
IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.
SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions
View original content: http://www.newswire.ca/en/releases/archive/October2018/16/c4239.html
/CONTACT:
IIROC Inquiries 1-877-442-4322 (Option 2) - Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.
/Web site: http://www.iiroc.ca/
Copyright CNW Group 2018
(END) Dow Jones Newswires
October 16, 2018 10:00 ET (14:00 GMT)
Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.
Market data and information provided by Morningstar.
Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
Information and news provided by ,, , Computrade Systems, Inc., , and
Copyright © 2018. All rights reserved.
CFRA Research Disclosure
3rd Party Research Disclosure
they stopped trading because of circuit breaker today. Whats that all about on a day like this?
018
10:51 am ET
*Canadian Research Firm Veritas Earlier Initiated Coverage On Aphria, Aurora Cannabis, Canopy Growth, Cronos Group With Sell Ratings
Benzing. What the hell is up with this picture. Why would they give us a sell rating?
I'm interested to know the percentage of the float! Does anyone have a clue? I hope not over 30%. Even that is a little high. On such good news Acbff should have flew off the handle but instead it closed down. Maybe tomorrow will be a better day.
Does anyone know if the filing forms for uplisting has been submitted yet? Its important to know this. Especially if its getting listed this month.
At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Aurora Cannabis Inc (ACBFF). If you are looking for stocks with good return, Aurora Cannabis Inc can be a profitable investment option. Aurora Cannabis Inc quote is equal to 9.350 USD at 2018-10-05. Based on our forecasts, a long-term increase is expected, the "ACBFF" stock price prognosis for 2023-09-27 is 31.119 USD. With a 5-year investment, the revenue is expected to be around +232.82%. Your current $100 investment may be up to $332.82 in 2023.
Current Price: 9.350 USD
7 Days Forecast
Get It Now!
1-Year Forecast *
? 15.085 USD
5-Year Forecast *
? 31.119 USD
Aurora Cannabis Inc. (OTCQX: ACBFF) is a Canadian company that's redefining the thriving cannabis space. One of Canada's leading licensed producers, Aurora Cannabis, has partnered with Elevate, Canada's Tech Week, to present a stand-out roster of panel discussions and interactive sessions with innovators and pioneers in the cannabis industry. As a gold partner of Elevate, Canada's largest tech and innovation festival, Aurora has been instrumental in shaping the Elevate Cannabis and Elevate Health tracks that will feature leading experts in research, medicine, finance and entrepreneurship in the cannabis industry. "We are thrilled to partner with Elevate this year. This conference is about showcasing Canada as a leader in technology as well as demonstrating a diverse and inclusive society. This is precisely what Aurora stands for - innovation, community, culture," says Paula Whitmore, Director, Partnerships and Events, Aurora. "The line-up of speakers and topics demonstrates our desire to work with different industries to develop innovative solutions and products in the recreational and medical environments."
Good informative article CLUCKY,Bravo!!!
God help us if there is a reverse split or even a split of any kind. I t truly will be the kiss of death,
#4 Aurora Cannabis Inc. (OTCQX:ACBFF) (TSX:ACB)
Cannabis Coke? It's no joke.
That's what Aurora Cannabis Inc. is attempting to do: fuse THC with fizzy drinks. And it has already attracted major attention, with talks of a buy-out from Coca Cola sending Aurora's stock shooting upwards on September 17.
Aurora declined to comment on the Coke rumors, but did nothing to halt the upward tick of the price which rose 5 percent and 64 percent in the last month.
The price has risen steadily, gaining 37 percent in the last month. Aurora was the No. 2 cannabis stock in terms of market cap, trailing only the heavy-hitter Canopy Growth Corp. Now it lags behind Tilray.
While the price ticked upward on the Coke rumors, Aurora remains underpriced when compared to Tilray or Canopy. That makes it a good candidate for an early buy-in or a hedge in case other cannabis stocks crash and burn.
Aurora had a high valuation even before this recent surge started sending pot stocks upwards. That makes it a safe bet, compared to the shooting stars like Tilray. When full legalization goes into effect on October 17, Aurora should expect strong sales and a healthy market share.
Thanks buddy!
Nafta deal a huge plus for Aurora Cant hurt. Before my mother passed last month the doctors in a major hospital in the US were giving her all kinds of marijuana medications for all sorts of pain ailments and the were extremely expensive. So I know first hand that these meds work and are important. She could not tolarate morphine and the pot meds were a great alternative.Thats just one hospital and if they are doing it Im sure other hospitals are doing it. This stock is going to explode here soon. All the numbers are showing it.All kind of Assets are going to be coming back to Canada for emerging markets and thats good for Aurora and thats great for Canada. Potentially great economic growth. Way to go Canada.
Today's News, September 28, 2018
1:39 pm ET
Pot Stocks & ETF: Risks and Rewards(Zacks) google this,
I have to know why Cam Battley resigned the Board of TGOD. Sometimes people in upper managment get fired and get the option of saying they resigned to save face. Its important to know why Cam resigned. In May Tgod was touting him as the best thing since sliced bread , what happened?To focus more on Aurora is not a good enough answer , what in May he didnt want to focus on Aurora that much.Something not right. He needs to hold a news briefing and let the stock holders know. Also if this was planned why did he not say anything about it at the conference.This is all too sudden. People of his caliber dont just quit.
There are now 3 highly credible analysts that have given Aurora a Strong Buy rating.There is also one that has given it a Hold. However none have given it a Sell. One also said it could easily double within the next 6 months.Of course keep in mind analysts are only speculating hypothetically, just an educated guess (running numbers). However I for one hope there's some truth to that. I think there is.